video

sound

Persian Version

View:

660

Download:

Cites:

Information Seminar Paper

Title

LIGAND DOCKING CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4- [(6-AMINO-4-PYRIMIDINYL) AMINO] BENZENESULFONAMIDE (U55)

Writers

ZAKER SEYEDEH N.

Pages

 Start Page | End Page

Abstract

 ONE OF MOLECULAR MODELLING TECHNIQUE IS PROTEIN LIGAND DOCKING. THE POSITION AND ORIENTATION OF MOLECULE IS PREDICTED WHEN IS BOUND TO ENZYME OR PROTEIN BY USING THE LIGAND DOCKING METHOD. CYCLIN-DEPENDENT KINASE 2 (CDK2) IS A MEMBER OF THE SER/THR PROTEIN KINASE FAMILY THAT IS INTERESTING FOR DRUG DESIGN BECAUSE SOME DISEASES SUCH AS CANCER ARE CREATED BY DISRUPTION IN THE REGULATION OF THE CELL CYCLES. IF A DRUG CAN INHIBIT CDK2 ACTIVITY, THEN THE UNCONTROLLED CELL REPLICATION IN CANCER CAN ALSO BE CONTROLLED. IN THIS WORK, CDK2 IS RECEPTOR AND 4- [(6-AMINO-4-PYRIMIDINYL) AMINO] BENZENESULFONAMIDE (U55) IS LIGAND. AS A RESULT, SOME HYDROGEN BOUNDS BETWEEN RECEPTOR AND LIGAND WERE OMITTED IN THE DOCKING STRUCTURE. HOWEVER, THE LOCATION OF DOCKING BETWEEN LIGAND AND THE CAVITY OF RECEPTOR IN THE LIGAND DOCKING METHOD IS SIMILAR TO THE EXPERIMENTAL STRUCTURE. THERE IS SIMILARITY IN MANY PARTS OF THE LIGANDS STRUCTURES AND THIS IS A GOOD REASON THAT THE COMPUTATIONAL LIGAND CAN BE DOCKED TO THE RECEPTOR THE SAME AS THE ORIGINAL LIGAND.

Cites

  • No record.
  • References

  • No record.
  • Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops